What Investors Need To Know About Pfizer's Potential Coronavirus Vaccine
Fool.com's Healthcare and Cannabis Bureau Chief Corinne Cardina interviewed Richard Horton on Motley Fool Live on Oct. 9. Horton runs the British medical journal The Lancet and has been at the forefront of publishing data about the coronavirus pandemic this year. He also recently published a book called The COVID-19 Catastrophe.
Here, Horton tells us what's so exciting about a potential mRNA vaccine candidate to prevent COVID-19, like that in development by Pfizer (NYSE: PFE) and BioNTech (NASDAQ: BNTX), as well as that in Moderna's (NASDAQ: MRNA) pipeline.
Source Fool.com
